AMAG Pharmaceuticals, Inc. to Host Conference Call on July 26, 2012 at 8:00 a.m. ET to Discuss Financial Results for the Quarter Ended June 30, 2012

LEXINGTON, Mass.–(BUSINESS WIRE)–Jul. 19, 2012–
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it will report
unaudited consolidated financial results for the quarter ended June 30,
2012 before the U.S. financial markets open on Thursday, July 26, 2012.
The announcement will be followed by a conference call and webcast with
slides at 8:00 a.m. ET during which management will provide a business
update and review second quarter financial results.

To access the conference call via telephone, please dial (877) 412-6083
from the United States or (702) 495-1202 for international access. A
telephone replay will be available from approximately 12:00 p.m. ET on
July 26, 2012 through midnight August 2, 2012. To access a replay of the
conference call, dial (855) 859-2056 from the United States or (404)
537-3406 for international access. The pass code for the live call and
the replay is 10874179.

The call will be webcast with slides and accessible through the
Investors section of the company’s website at www.amagpharma.com.
The webcast replay will be available from approximately 11:00 a.m.
ET on July 26, 2012 through midnight August 26, 2012.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
development and commercialization of a therapeutic iron compound to
treat iron deficiency anemia. AMAG manufactures and sells Feraheme®
(ferumoxytol) Injection for intravenous use. For additional company or
product information, please visit www.amagpharma.com
or http://feraheme.com.

Feraheme is a registered trademark of AMAG Pharmaceuticals, Inc.

Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303